UNSPSC 51372022: Buprenorphine hydrochloride

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51372022

Definition

This classification denotes an opioid receptor agonist and opioid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 56W8MW3EN1. European Medicines Agency schedules Buprenorphine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13133MIG. Buprenorphine hydrochloride generally arises in the molecular formula C29H41NO4.CLH. The term 'buprenorphine hydrochloride' is a United States Adopted Name designation.

Read the full definition

Most nations, for tariff and trade purposes, schedule buprenorphine hydrochloride under HS 29391100 and SITC 54141. As of Q4 2014, BUPRENORPHINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Buprenorphine hydrochloride bears US NLM identifiers UMLS ID C0006404 and NCI Concept Code C47424. SMILES: C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6C5C(C(CC6)O)O4)CC7CC7)OC)(C(C)(C)C)O.CL.

About UNSPSC 51372022

UNSPSC 51372022 Buprenorphine hydrochloride is a Commodity code for pharmaceutical products used in opioid use disorder treatment and pain management. State and local governments purchase buprenorphine primarily through public health departments, county health systems, and community health agencies to support medication-assisted treatment programs and overdose prevention initiatives. The procurement landscape under this code spans health departments managing substance-use treatment networks, county health authorities, and specialized community health organizations. Buprenorphine is typically procured as part of broader public health strategies addressing opioid-use epidemiology and addiction treatment access; purchases are often bundled with related harm-reduction products such as naloxone and drug deactivation systems or requested alongside clinical services and training.

Recent state and local activity remains limited in the public record. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid response deadline was July 26, 2023. This solicitation, though tagged under the buprenorphine commodity code, concerns naloxone and drug deactivation systems rather than buprenorphine itself, suggesting possible classification misalignment in the county's procurement records. Florida emerges as the primary jurisdiction with visible recent activity under this code, though broader geographic coverage and issuing-body concentration cannot be characterized from the available opportunities block. The Seminole County procurement required E-Verify compliance, drug-free workplace certification, and carried a two-year initial term with optional one-year renewal; FEMA funding was noted as a potential source, introducing federal regulatory compliance layers.

Quick answers

What is UNSPSC 51372022?

UNSPSC 51372022 is Buprenorphine hydrochloride, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51372022?

UNSPSC 51372022 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51372022

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code